Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Change in Accured Expenses (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Change in Accured Expenses for 14 consecutive years, with $958000.0 as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 13.46% to $958000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, up 52.65% year-over-year, with the annual reading at $1.8 million for FY2025, 52.65% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $958000.0 at Niagen Bioscience, down from $1.3 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $1.6 million in Q1 2022, with the low at -$1.8 million in Q2 2024.
  • Average Change in Accured Expenses over 5 years is $320350.0, with a median of $860000.0 recorded in 2021.
  • The sharpest move saw Change in Accured Expenses tumbled 58566.67% in 2021, then soared 1756.67% in 2023.
  • Over 5 years, Change in Accured Expenses stood at $150000.0 in 2021, then skyrocketed by 287.33% to $581000.0 in 2022, then crashed by 48.36% to $300000.0 in 2023, then skyrocketed by 269.0% to $1.1 million in 2024, then decreased by 13.46% to $958000.0 in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $958000.0, $1.3 million, and -$1.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.